729 related articles for article (PubMed ID: 15588425)
21. Cultured astrocytes express toll-like receptors for bacterial products.
Bowman CC; Rasley A; Tranguch SL; Marriott I
Glia; 2003 Sep; 43(3):281-91. PubMed ID: 12898707
[TBL] [Abstract][Full Text] [Related]
22. IFN-alpha regulates TLR-dependent gene expression of IFN-alpha, IFN-beta, IL-28, and IL-29.
Sirén J; Pirhonen J; Julkunen I; Matikainen S
J Immunol; 2005 Feb; 174(4):1932-7. PubMed ID: 15699120
[TBL] [Abstract][Full Text] [Related]
23. Toll-like receptor expression and responsiveness are increased in viraemic HIV-1 infection.
Lester RT; Yao XD; Ball TB; McKinnon LR; Kaul R; Wachihi C; Jaoko W; Plummer FA; Rosenthal KL
AIDS; 2008 Mar; 22(6):685-94. PubMed ID: 18356597
[TBL] [Abstract][Full Text] [Related]
24. Activation of mast cells by double-stranded RNA: evidence for activation through Toll-like receptor 3.
Kulka M; Alexopoulou L; Flavell RA; Metcalfe DD
J Allergy Clin Immunol; 2004 Jul; 114(1):174-82. PubMed ID: 15241362
[TBL] [Abstract][Full Text] [Related]
25. Toll-like receptor expression in murine DC subsets: lack of TLR7 expression by CD8 alpha+ DC correlates with unresponsiveness to imidazoquinolines.
Edwards AD; Diebold SS; Slack EM; Tomizawa H; Hemmi H; Kaisho T; Akira S; Reis e Sousa C
Eur J Immunol; 2003 Apr; 33(4):827-33. PubMed ID: 12672047
[TBL] [Abstract][Full Text] [Related]
26. Differential expression and regulation of toll-like receptors (TLR) in human leukocytes: selective expression of TLR3 in dendritic cells.
Muzio M; Bosisio D; Polentarutti N; D'amico G; Stoppacciaro A; Mancinelli R; van't Veer C; Penton-Rol G; Ruco LP; Allavena P; Mantovani A
J Immunol; 2000 Jun; 164(11):5998-6004. PubMed ID: 10820283
[TBL] [Abstract][Full Text] [Related]
27. Microglia Induce Neurotoxic IL-17+ γδ T Cells Dependent on TLR2, TLR4, and TLR9 Activation.
Derkow K; Krüger C; Dembny P; Lehnardt S
PLoS One; 2015; 10(8):e0135898. PubMed ID: 26288016
[TBL] [Abstract][Full Text] [Related]
28. Roles of toll-like receptors in C-C chemokine production by renal tubular epithelial cells.
Tsuboi N; Yoshikai Y; Matsuo S; Kikuchi T; Iwami K; Nagai Y; Takeuchi O; Akira S; Matsuguchi T
J Immunol; 2002 Aug; 169(4):2026-33. PubMed ID: 12165529
[TBL] [Abstract][Full Text] [Related]
29. Colony-stimulating factor-1 suppresses responses to CpG DNA and expression of toll-like receptor 9 but enhances responses to lipopolysaccharide in murine macrophages.
Sweet MJ; Campbell CC; Sester DP; Xu D; McDonald RC; Stacey KJ; Hume DA; Liew FY
J Immunol; 2002 Jan; 168(1):392-9. PubMed ID: 11751985
[TBL] [Abstract][Full Text] [Related]
30. Bacterial peptidoglycans but not CpG oligodeoxynucleotides activate synovial fibroblasts by toll-like receptor signaling.
Kyburz D; Rethage J; Seibl R; Lauener R; Gay RE; Carson DA; Gay S
Arthritis Rheum; 2003 Mar; 48(3):642-50. PubMed ID: 12632416
[TBL] [Abstract][Full Text] [Related]
31. Vascular cell responsiveness to Toll-like receptor ligands in carotid atheroma.
Erridge C; Burdess A; Jackson AJ; Murray C; Riggio M; Lappin D; Milligan S; Spickett CM; Webb DJ
Eur J Clin Invest; 2008 Oct; 38(10):713-20. PubMed ID: 18837796
[TBL] [Abstract][Full Text] [Related]
32. Synergistic induction of CXCL9 and CXCL11 by Toll-like receptor ligands and interferon-gamma in fibroblasts correlates with elevated levels of CXCR3 ligands in septic arthritis synovial fluids.
Proost P; Verpoest S; Van de Borne K; Schutyser E; Struyf S; Put W; Ronsse I; Grillet B; Opdenakker G; Van Damme J
J Leukoc Biol; 2004 May; 75(5):777-84. PubMed ID: 14996826
[TBL] [Abstract][Full Text] [Related]
33. TLR activation pathways in HIV-1-exposed seronegative individuals.
Biasin M; Piacentini L; Lo Caputo S; Naddeo V; Pierotti P; Borelli M; Trabattoni D; Mazzotta F; Shearer GM; Clerici M
J Immunol; 2010 Mar; 184(5):2710-7. PubMed ID: 20124101
[TBL] [Abstract][Full Text] [Related]
34. A type I interferon autocrine-paracrine loop is involved in Toll-like receptor-induced interleukin-12p70 secretion by dendritic cells.
Gautier G; Humbert M; Deauvieau F; Scuiller M; Hiscott J; Bates EE; Trinchieri G; Caux C; Garrone P
J Exp Med; 2005 May; 201(9):1435-46. PubMed ID: 15851485
[TBL] [Abstract][Full Text] [Related]
35. TLRs and NODs mRNA expression pattern in healthy mouse eye.
Rodríguez-Martínez S; Cancino-Díaz ME; Jiménez-Zamudio L; García-Latorre E; Cancino-Díaz JC
Br J Ophthalmol; 2005 Jul; 89(7):904-10. PubMed ID: 15965176
[TBL] [Abstract][Full Text] [Related]
36. Toll-like receptor signaling inhibits hepatitis B virus replication in vivo.
Isogawa M; Robek MD; Furuichi Y; Chisari FV
J Virol; 2005 Jun; 79(11):7269-72. PubMed ID: 15890966
[TBL] [Abstract][Full Text] [Related]
37. A distinct Toll-like receptor repertoire in human tonsillar B cells, directly activated by PamCSK, R-837 and CpG-2006 stimulation.
Månsson A; Adner M; Höckerfelt U; Cardell LO
Immunology; 2006 Aug; 118(4):539-48. PubMed ID: 16780564
[TBL] [Abstract][Full Text] [Related]
38. Selected Toll-like receptor agonist combinations synergistically trigger a T helper type 1-polarizing program in dendritic cells.
Napolitani G; Rinaldi A; Bertoni F; Sallusto F; Lanzavecchia A
Nat Immunol; 2005 Aug; 6(8):769-76. PubMed ID: 15995707
[TBL] [Abstract][Full Text] [Related]
39. Toll-like receptors 2 and 4 are up-regulated during intestinal inflammation.
Hausmann M; Kiessling S; Mestermann S; Webb G; Spöttl T; Andus T; Schölmerich J; Herfarth H; Ray K; Falk W; Rogler G
Gastroenterology; 2002 Jun; 122(7):1987-2000. PubMed ID: 12055604
[TBL] [Abstract][Full Text] [Related]
40. Differential regulation of Toll-like receptor mRNAs in experimental murine central nervous system infections.
Böttcher T; von Mering M; Ebert S; Meyding-Lamadé U; Kuhnt U; Gerber J; Nau R
Neurosci Lett; 2003 Jun; 344(1):17-20. PubMed ID: 12781911
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
